AbbVie Management to Discuss Strategy at Morgan Stanley Healthcare Forum
Executives from North Chicago-based pharmaceutical giant AbbVie are scheduled to headline the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. The session, formatted as a fireside chat, will offer investors and analysts a direct look at the company’s current pipeline and therapeutic priorities.
The presentation is slated for 9:00 a.m. Central time. Shareholders and industry observers can track the discussion via a live audio webcast hosted on the AbbVie Investor Relations portal. For those unable to join the session in real time, the firm plans to release an archived recording of the talk on the same day.
AbbVie continues to focus its research and commercial efforts on high-stakes therapeutic sectors, including immunology, oncology, and neuroscience. Alongside its pharmaceutical pipeline, the company maintains its Allergan Aesthetics portfolio as a core segment of its market strategy.
Comments (0)
No comments yet. Be the first!